Skip to content

Combination of Lymphatico-venular Anastomosis and Liposuction to Treat Cancer-related Lymphedema

Combination of Lymphatico-venular Anastomosis and Liposuction to Treat Cancer-related Lymphedema: Rationale for a Regional Approach

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05025982
Enrollment
24
Registered
2021-08-30
Start date
2018-08-01
Completion date
2025-05-01
Last updated
2021-08-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Combination of LVA and Liposuction Guarantees Long Lasting Results, Description of an Effective Surgical Strategy to Treat Cancer-related Lymphedema

Brief summary

* cooperation of an International team with many years of experience in surgical management of lymphedema * description of an effective surgical strategy to treat cancer-related lymphedema, a high incidence pathology * the combination of LVA and liposuction guarantees long lasting results

Detailed description

Cancer-related lymphedema represents one of the major complications of cancer treatment, especially for breast and gynecologic cancers. Moreover, it has high impact on cancer survivors and healthcare systems. Lymphedema management still remains challenging. The better understanding of lymphedema physiopathology as well as the development of sophisticated surgical and diagnostic techniques have led to effective strategies to address lymphedema patients but, despite the considerable interest in international literature, no consensus exist. The combination of LVA and liposuction may represent an effective strategy in treating patients with cancer-related lymphedema, in order to reach a significant decrease in volume and reduction of lymphangitis rate as well as stable results in time. In addition, it has the aim of being minimally invasive and well tolerated by patients

Interventions

PROCEDUREcombination of lymphaticovenular anastomosis and liposuction

Surgeries were carried out under local anesthesia and light sedation.LVA was performed adopting supramicrosurgical technique.Liposuction was performed following completion of the LVA

Sponsors

University of Siena
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

patients affected by secondary lymphedema * free from cancer disease

Exclusion criteria

\- persistence of the neoplastic pathology \- patients affected by primary lymphedema

Design outcomes

Primary

MeasureTime frameDescription
change in volumeone yearchange in volume of the limb affected by cancer-related lymphedema

Countries

Italy

Contacts

Primary ContactGuido Gabriele, MD
guidogabriele1@yahoo.it3351355043

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026